0

Heart Failure Collection
 21-30 of 30 Articles
ACP Journal Club |  19 January 2010
A model combining clinical assessment and NT-proBNP level accurately predicted heart failure in ED patients with dyspnea
James Brophy, MD, PhD
Ann Intern Med. 2010;152(2):JC1-13. doi:10.7326/0003-4819-152-2-201001190-02013
ACP Journal Club |  16 June 2009
Use of nonsteroidal antiinflammatory drugs was associated with increased risks for death and hospitalization for MI and HF
David Siegel, MD, MPH
Ann Intern Med. 2009;150(12):JC6-12. doi:10.7326/0003-4819-150-12-200906160-02012
ACP Journal Club |  19 May 2009
Irbesartan did not reduce all-cause death or CV hospitalization in heart failure and preserved ejection fraction
Justin A. Ezekowitz, MD; Finlay A. McAlister, MD
Ann Intern Med. 2009;150(10):JC5-10. doi:10.7326/0003-4819-150-10-200905190-02010
ACP Journal Club |  17 March 2009
Review: Perioperative β-blockers provide no clear benefit in patients having noncardiac surgery
Ryan J. McColl, MD; Elijah Dixon, MD
Ann Intern Med. 2009;150(6):JC3-4. doi:10.7326/0003-4819-150-6-200903170-02004
ACP Journal Club |  20 January 2009
n-3 polyunsaturated fatty acids reduced morbidity and mortality in chronic heart failure
James M. Brophy, MD, PhD
Ann Intern Med. 2009;150(2):JC1-11. doi:10.7326/0003-4819-150-2-200901200-02011
ACP Journal Club |  21 October 2008
Rhythm control and rate control did not differ for CV mortality in atrial fibrillation and congestive heart failure
John Cairns, MD
Ann Intern Med. 2008;149(4):JC4-8. doi:10.7326/0003-4819-149-8-200810210-02008
ACP Journal Club |  16 September 2008
Review: Celecoxib increases risk for cardiovascular events; risks are greatest with higher doses
Bruce Rothschild, MD
Ann Intern Med. 2008;149(6):JC3-15. doi:10.7326/0003-4819-149-6-200809160-02015
ACP Journal Club |  17 June 2008
Evidence-based medicine targets the individual patient. Part 1: How clinicians can use study results to determine optimal individual care
Dirk Bassler, MD, MSc; Jason W. Busse, DC, MSc; Paul J. Karanicolas, MD, PhD; et al.
Ann Intern Med. 2008;148(12):JC4-2. doi:10.7326/0003-4819-148-12-200806170-02002
ACP Journal Club |  17 June 2008
Thiazolidinediones increased risk for heart failure, myocardial infarction, and death in older patients with type 2 diabetes
Raj Padwal, MD
Ann Intern Med. 2008;148(12):JC4-13. doi:10.7326/0003-4819-148-12-200806170-02013
ACP Journal Club |  Jan/Feb 2000
Controlled- and extended-release metoprolol reduced mortality in congestive heart failure
Robert S. McKelvie, MSc, MD, PhD
Ann Intern Med. 2000;132(1):3. doi:10.7326/ACPJC-2000-133-1-003
Advertisement

Buy This Article

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)